| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.62▼ | 1.63▼ | 1.63▼ | 1.56▲ | 1.37▲ |
| MA10 | 1.62▼ | 1.63▼ | 1.60▲ | 1.41▲ | 1.31▲ |
| MA20 | 1.62▼ | 1.58▲ | 1.56▲ | 1.31▲ | 1.28▲ |
| MA50 | 1.58▲ | 1.59▲ | 1.48▲ | 1.26▲ | 1.71▼ |
| MA100 | 1.56▲ | 1.41▲ | 1.35▲ | 1.27▲ | 1.84▼ |
| MA200 | 1.55▲ | 1.31▲ | 1.28▲ | 1.69▼ | 1.46▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.004▼ | 0.004▲ | 0.003▲ | 0.043▲ | 0.071▲ |
| RSI | 50.134▲ | 52.917▲ | 54.394▲ | 67.516▲ | 55.177▲ |
| STOCH | 50.790 | 64.866 | 76.943 | 23.986 | 48.642 |
| WILL %R | -58.824 | -30.435 | -30.435 | -71.777 | -62.565 |
| CCI | -11.597 | 21.269 | 42.179 | 88.695 | 166.347▲ |
|
Tuesday, June 23, 2026 01:34 AM
Entera Bio (NASDAQ:ENTX) has been pursuing that same vision in osteoporosis, and this morning the company announced what may be the most significant regulatory milestone in its history. Entera ...
|
|
Tuesday, June 16, 2026 05:41 AM
EB612, a first-in-class long-acting PTH(1-34) oral peptide for hypoparathyroidism, produced robust bioavailability and sustained increases in calcium across three preclinical models; IND is expected ...
|
|
Monday, June 01, 2026 10:14 AM
Track conference calls, annual meetings, summits, analyst days and other corporate events scheduled for Entera Bio Ltd. Use the full market events calendar to scan activity across all tickers. Loading ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 29/06/26 | 1.59 | 1.66 | 1.59 | 1.61 | 435,908 |
| 26/06/26 | 1.39 | 1.69 | 1.38 | 1.63 | 417,560 |
| 25/06/26 | 1.56 | 1.57 | 1.44 | 1.45 | 294,674 |
| 24/06/26 | 1.58 | 1.67 | 1.45 | 1.54 | 613,154 |
| 23/06/26 | 1.36 | 1.60 | 1.282 | 1.55 | 1,834,199 |
| 22/06/26 | 1.24 | 2.7799 | 1.22 | 1.48 | 52,309,151 |
| 18/06/26 | 1.20 | 1.22 | 1.1686 | 1.21 | 51,008 |
| 17/06/26 | 1.18 | 1.23 | 1.16 | 1.20 | 29,432 |
| 16/06/26 | 1.21 | 1.21 | 1.16 | 1.18 | 88,034 |
| 15/06/26 | 1.25 | 1.25 | 1.17 | 1.21 | 86,591 |
|
|
||||
|
|
||||
|
|